Ind-Swift has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines.
It has developed Netazoxanide Anti-Diarrheal drug for the first time in India after successful clinical trials and bio-equivalence studies.
It has strong capacity to develop non infringing API's requiring Complex Chemistry and Multiple reactions.
Ind-Swift has developed taste masking technology of macrolides for the first time in India.
Ind-Swift has developed the sustained release process of Isoxsuprine HCL tablets for the first time in India.
Ind-Swift has developed the mouth desolving tablet.
